Cite
HARVARD Citation
Marconcini, R. et al. (n.d.). 2249 Comparison of Everolimus (EV) plus somatostatin analog (SSA) administered before or after chemotherapy (CT) or PRRT in advanced G1-G2 Neuroendocrine Tumor (NET) progressed after SSA: analysis of different sequences in single center experience. European journal of cancer. pp. S415-S416. [Online].